Search Results
Sep 03, 2025, 08:30 ET AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
serious side effects, including: Cytokine release syndrome (CRS), which is common during treatment with EPKINLY and can be serious or life-threatening. To help reduce your risk of CRS, you will receive EPKINLY on a step-up dosing schedule (when you receive 2 or 3 smaller
More news about: AbbVie
Sep 02, 2025, 17:31 ET Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in the 7MM during the Forecast Period (2025-2034)
Clostridioides Difficile infection therapies in clinical trials include MBK-01, VE303, LMN-201, Ibezapolstat, CRS3123, NTCD-M3 (VP20621), PF-07831694, IDOR-1134-2831 and others.In the EU, fecal microbiota transplantation (FMT) has not
More news about: DelveInsight Business Research, LLP
Sep 02, 2025, 11:00 ET Bastion Fiduciary Marks 12th Anniversary of Actively Managed International Portfolios
For additional information about Bastion Fiduciary, including fees and services, please contact us or refer to our Form ADV Part 2A Brochure and Form CRS available on the SEC's Investment Adviser Public Disclosure website.
More news about: Bastion Fiduciary
Sep 02, 2025, 08:30 ET Hong Kong Reinforces Regulated Crypto Bridge as Asian Institutional Demand Surges
high-performance computing data centers and provides secure cloud and AI infrastructure in partnership with key players such as NVIDIA, Deloitte and 2CRS. These bold strategies underscore the accelerating convergence of innovative finance, digital assets and cutting-edge infrastructure. Digital-
More news about: NetworkNewsWire
Aug 28, 2025, 08:15 ET Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Aug 28, 2025, 08:05 ET Redox Accelerates Growth in Midwest Agriculture
Redox Midwest team, he now formally leads Redox's expansion efforts across the Midwest. "As a grower and someone fully invested in the region, CR's passion, agronomic knowledge and understanding of what growers need to thrive are a perfect fit for our technology," Moon said. "Redox has a
More news about: Redox Bio-Nutrients
Aug 27, 2025, 10:40 ET Harbour BioMed Reports 2025 Interim Results
activation and cell elimination. By incorporating dual anti-BCMA binding sites for optimal cell targeting and monovalent-optimized CD3 activity to minimize CRS, HBM7020 demonstrated potent cytotoxicity with broad applications in both immunological and oncology diseases. In August 2023,
More news about: Harbour BioMed
Aug 27, 2025, 06:30 ET Global CAR-T Cell Therapy Market to Hit $217.6Bn by 2035 at 39.75% CAGR | Vantage Market Research
stages.Safety Risks and Side Effects Despite high efficacy, CAR-T therapy carries risks of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).Managing these side effects requires specialized healthcare infrastructure
More news about: Vantage Market Research
Aug 26, 2025, 14:35 ET CAR-T Cell Therapy Market to Reach USD 11,142.53 million by 2032, growing at a CAGR of 12.3%: Credence Research
in scaling up treatments for global demand. Safety and Side Effects Severe adverse effects, such as cytokine release syndrome (CRS) and neurotoxicity, pose clinical risks and limit patient eligibility. Managing these side effects requires specialized infrastructure and skilled professionals,
More news about: Credence Research Inc.
Aug 26, 2025, 14:21 ET Wisner Baum Warns: New Pesticide Immunity Laws Put Public Health and Corporate Accountability at Risk
Insecticide, Fungicide, and Rodenticide Act. Congressional Research Service, 2 May 2025, congress.gov/crs_external_products/LSB/PDF/LSB11304/LSB11304.1.pdf.Media Inquiries: Karla Jo Helms JOTO PR ™ 727-777-4629 Jotopr.com
More news about: Wisner Baum
Aug 26, 2025, 08:00 ET Dominari Holdings Forms Crypto Advisory Board to Support Strategic Expansion
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Aug 25, 2025, 03:00 ET Antengene Announces 2025 Interim Results with Encouraging Clinical Data and Progress in TCE Platform
engager technology, featuring "2+1" bivalent binding, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to reduce CRS and improve efficacy. Broadly applicable across autoimmune diseases, solid tumors, and hematologic malignancies, the platform is open to global partnerships.
More news about: Antengene Corporation Limited
Aug 22, 2025, 09:15 ET Dominari Holdings Announces Record Date for Cash Dividend
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Aug 22, 2025, 06:11 ET Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform
for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune diseases, solid tumors and hematological
More news about: Antengene Corporation Limited
Aug 21, 2025, 16:18 ET NASA's SpaceX CRS-33 to Advance Tissue Engineering, Stem Cell Research, and Space Computing
Fla., Aug. 21, 2025 /PRNewswire/ -- SpaceX's 33rd commercial resupply services (CRS) mission, funded by NASA, is slated to launch no earlier than 2:45 a.m. EDT on Sunday, August 24, from Cape Canaveral Space Force Station in Florida.
More news about: International Space Station National Lab
Aug 21, 2025, 05:13 ET H World Group 資產輕策略推動第 2 季度業績強勁
1,500 間酒店。城際酒店推動該部門業績增長，較去年同期增長 57.1%，反映高檔產品需求強勁。城際、漢庭和桔子的成就突顯該集團強大兼多樣化品牌組合對客人和合作夥伴的吸引力。 客戶忠誠度和直接參與度持續增強，截至 6 月 30 日，會員數已達 2.88 億。透過 H World CRS 直接預訂佔總預訂量的 65.1%，這較去年增長 5.2 個百分點，反映該集團數碼平台的效用。 對增長動力感到樂觀 截至 6 月 30 日，H World 正在全球發展總共 2,947 間酒店。 「我們對中國旅遊及酒店業的長遠增長，仍然感到樂觀。我們將繼續專注於提升自身核心競爭力、拓展我們的優質網絡、升級我們的供應鏈、提升我們的品牌定位及『卓越服務』，並增強我們的銷售能力。」金輝先生表示。
More news about: H World Group
Aug 20, 2025, 10:00 ET H World Group Reports Robust Q2 Results, Driven by Asset-light Strategy
engagement continued to strengthen, with membership reaching 288 million as of June 30. Direct bookings through H World CRS accounted for 65.1% of total reservations, representing a 5.2 percentage point increase from the prior year, reflecting the effectiveness of the Group's
More news about: H World Group
Aug 19, 2025, 08:00 ET Dominari Holdings Featured in The Wall Street Journal
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Aug 19, 2025, 06:39 ET Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma
for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune disease, solid tumors and hematological malignancies
More news about: Antengene Corporation Limited
Aug 19, 2025, 00:42 ET Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma
for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune disease, solid tumors and hematological malignancies
More news about: Antengene Corporation Limited
Aug 12, 2025, 14:47 ET ISS National Lab and NASA to Highlight R&D on Next Cargo Mission to Space Station
NASA's SpaceX CRS-31 in 2024 About the International Space Station (ISS) National Laboratory:The International Space Station (ISS) is a
More news about: International Space Station National Lab
Aug 12, 2025, 09:15 ET Dominari Marks Inflection Point with Second Quarter 2025 Financial Results
all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at
More news about: Dominari Holdings Inc.
Aug 12, 2025, 09:00 ET VELOCITY STABILIZES RESTOMOD INDUSTRY WITH THE ACQUISITION OF CLASSIC RECREATIONS
While Velocity had no prior connection to Classic Recreations, the company's leadership quickly responded after learning of CR's sudden closure, which left many customers without support and a number of vehicle builds incomplete. Stepping in as a stabilizing force for the restomod
More news about: Velocity Modern Classics
Aug 11, 2025, 11:26 ET Alliance for OpenUSD Announces New Members, Inclusive Language Guide, and Core Specification Progress
government, urban planning, utilities, and transportation. A foundational element of geospatial workflows is the use of coordinate reference systems (CRS) to define location. Esri looks forward to sharing its expertise and leadership in this area with the OpenUSD community." – Jim
More news about: The Linux Foundation
Aug 07, 2025, 17:16 ET CHICAGO RIVER SWIM APROBADO PARA UN REGRESO HISTÓRICO ESTE SEPTIEMBRE
es líder en reconocer el papel considerable que nuestros ríos pueden desempeñar en la salud pública y en un futuro resiliente al clima". CRS también se ha asociado con la usa Swimming Foundation y contará con la participación de la olímpica 2020 Natalie Hinds, 20 veces medallista
More news about: A Long Swim